Low-dose ovulation induction with urinary gonadotropins or recombinant follicle stimulating hormone in patients with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 18, Issue 1, 2004, Pages 17-22

  Szilagyi A ^a   Bartfai G ^b   Manfai A ^a   Koloszar S ^b   Pal A ^b   Szabo I ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Gonadotropins; Infertility; Ovulation Induction; Polycystic Ovary Syndrome

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE; ESTRADIOL; GONADOTROPIN; PROGESTERONE; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

ANOVULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEMALE INFERTILITY; HUMAN; LOW DRUG DOSE; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME;

DRUG ADMINISTRATION SCHEDULE; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; HUNGARY; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; MENOTROPINS; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 1642455926     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590310001651731     Document Type: Article

References (21)

1. Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986;293:355-9
2. Homburg R. Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod 1996;11:29-39
3. Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995;16:322-53
4. Dunaif A. Insulin resistance in polycystic ovary syndrome. Ann NY Acad Sci 1993;687:60-4
5. Szilágyi A, Rossmanith WG. Polyzystisches Ovar-Syndrom: Zentrale oder periphere Regulations-ṡtörung? Zentralbl Gynäkol 1991;113:851-6
6. Szilágyi A, Hole R, Keckstein J, et al. Effects of ovarian surgery on the dopaminergic and opioidergic control of gonadotropin and prolactin secretion in women with polycystic ovarian disease. Gynecol Endocrinol 1993;7:159-66
7. Adams J, Franks S, Polson DW, et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone. Lancet 1985;2:1375-8
8. Shoham Z, Borenstein R, Lunenfeld B, et al. Hormonal profiles following clomiphene citrate therapy in conception and nonconception cycles. Clin Endocrinol 1990;33:271-8
9. Hedon B, Hugues JN, Emperaire JC, et al. A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women. Hum Reprod 1998;13:2688-92
10. Gleicher N, Oleske DM, Tur-Kaspa I, et al. Reducing the risk of high-order multiple pregnancy after ovarian stimulation with gonadotropins. N Engl J Med 2000;343:2-7
11. Daya S, Gunby J. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction. Hum Reprod 1999;14: 2207-15
12. Shoham Z, Patel A, Jacobs HS. Polycystic ovary syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle stimulating hormone. Fertil Steril 1991;55:1051-6
13. Homburg R, Levy T, Ben-Rafael Z. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for ovulation associated with polycystic ovary syndrome. Fertil Steril 1995;63: 729-33
14. Balen AH. Hypersecretion of LH: a significants cause of infertility and miscarriage. Br J Obstet Gynaecol 1993;100:1082-9
15. Recombinant Human FSH Study Group. Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil Steril 1995; 63:77-86
16. Frydman R, Howles CM, Truong F, for The French Multicentre Trialists. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. Hum Reprod 2000;15:520-5
17. Hamilton-Fairley D, Kiddy D, Watson H, et al. Low dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome. Hum Reprod 1991;6: 1095-9
18. Serono study 5642, data on file. Geneva, Switzerland: Serono
19. Coelingh Bennink HJT, Fauser BCJM, Out HJ. Recombinant follicle stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a progressive, multicenter, assessor blind, randomized, clinical trial. Fertil Steril 1998;69:19-25
20. Bayram N, van Wely M, van der Veen F. Recombinant FSH versus urinary gonadotropins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome (Cochrane Review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2002
21. Hayden CJ, Rutherfold AJ, Balen AH. Induction of ovulation with the use of a starting dose of 50 units of recombinant human follicle-stimulating hormone (Puregon). Fertil Steril 1999;71:106-8